Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.190
-0.050 (-2.23%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Daré Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
3228273070153
Upgrade
Market Cap Growth
24.55%1.59%-10.87%-56.74%-54.05%178.42%
Upgrade
Enterprise Value
107171731108
Upgrade
Last Close Price
2.191.933.123.719.9624.00
Upgrade
PS Ratio
30.9526.772774.4510.857.04-
Upgrade
PB Ratio
11.179.70-4.51-6.036.343.95
Upgrade
P/TBV Ratio
11.229.70--6.343.95
Upgrade
P/FCF Ratio
--5.54---
Upgrade
P/OCF Ratio
--4.96---
Upgrade
EV/Sales Ratio
9.547.221769.855.973.06-
Upgrade
EV/FCF Ratio
--3.53---
Upgrade
Debt / Equity Ratio
0.930.93-0.22-0.280.040.01
Upgrade
Debt / FCF Ratio
--0.27---
Upgrade
Net Debt / Equity Ratio
-7.76-7.762.391.80-3.08-1.33
Upgrade
Net Debt / EBITDA Ratio
1.851.850.620.301.091.32
Upgrade
Net Debt / FCF Ratio
2.152.15-2.940.231.881.79
Upgrade
Asset Turnover
0.040.0400.090.20-
Upgrade
Quick Ratio
1.071.070.740.561.153.29
Upgrade
Current Ratio
1.141.140.850.861.363.45
Upgrade
Return on Equity (ROE)
----994.69%-124.12%-205.82%
Upgrade
Return on Assets (ROA)
-31.04%-31.04%-67.57%-59.02%-39.38%-77.08%
Upgrade
Return on Capital Employed (ROCE)
-154.20%-154.20%-4805.00%-3834.00%-257.20%-98.30%
Upgrade
Earnings Yield
-42.02%-48.59%-14.93%-99.03%-43.96%-25.26%
Upgrade
FCF Yield
-32.21%-37.24%18.05%-129.65%-25.78%-18.79%
Upgrade
Buyback Yield / Dilution
-31.55%-31.55%-16.80%-3.23%-38.29%-103.23%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.